BiotechTube
Orion Pharma

Orion Pharma

London, United Kingdom· Est.
orionpharma.co.uk
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Orion Pharma is a publicly traded, diversified pharmaceutical company with a mission to develop innovative and generic treatments that enhance human and animal health. Its strategy leverages deep expertise in small molecule drug development across proprietary R&D in oncology and pain, a robust generic drugs portfolio, and a global API business to drive growth. The company aims to become a truly global, patient-focused innovator by the 2030s, balancing commercial execution with a strong sustainability ethos.

OncologyPain ManagementRespiratory diseasesNeurological diseasesWomen’s healthVeterinary

Technology Platform

Core expertise in the end-to-end research, development, and manufacturing of small molecule drugs, with deep capabilities in medicinal chemistry, formulation, and scalable API production.

FDA Approved Drugs

7
STALEVO 50NDAJun 11, 2003
STALEVO 75NDAJun 11, 2003
STALEVO 150NDAJun 11, 2003

Opportunities

Significant opportunities exist in the large, underserved pain management market for non-addictive therapies and in the high-value oncology sector.
Further growth is driven by generic drug market expansion, API outsourcing trends, and the resilient veterinary pharmaceuticals segment.

Risk Factors

Key risks include clinical failure of the proprietary R&D pipeline, intense pricing pressure and competition in the generics market, regulatory compliance challenges across numerous countries, and vulnerability to patent expiries on key products.

Competitive Landscape

Orion faces distinct competition: in proprietary R&D against large pharma and biotech innovators; in generics against large-scale global manufacturers on price; and in APIs against European and Asian producers on quality and cost. Its diversification is a primary competitive defense.

More companies in Small Molecule Drugs →More companies in United Kingdom →